Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hanna Bukowska is active.

Publication


Featured researches published by Hanna Bukowska.


Medical Science Monitor | 2013

Association between low-dose folic acid supplementation and blood lipids concentrations in male and female subjects with atherosclerosis risk factors.

Artur Mierzecki; Karolina Kłoda; Hanna Bukowska; Kornel Chełstowski; Magdalena Makarewicz-Wujec; Małgorzata Kozłowska-Wojciechowska

Background Folic acid (FA) is one of the B complex vitamins. It is thought that FA deficiency promotes atherosclerosis formation in arterial endothelium. FA, acting through reducing homocysteine (Hcy) levels, may contribute to decreased cholesterol (Ch) synthesis. The aim of this study was to analyze the association of low-dose folic acid supplementation with blood lipids concentrations in subjects with atherosclerosis risk factors. Material/Methods The study enrolled 124 Caucasian individuals (60 M, ages 20–39; and 64 F, ages 19–39) with atherosclerosis risk factors (family history of premature ischemic stroke, arterial hypertension, dyslipidemia, overweight and obesity, cigarette smoking, and low level of physical activity). The participants were asked to take FA at a low dose of 0.4 mg/24 h for 12 weeks. Results FA levels increased in females (6.3 vs. 12.5 ng/dL; p=0.001) and males (6.4 vs. 11.4 ng/dL; p=0.001) and Hcy levels decreased (10.6 vs. 8.3 μmol/L; p=0.001 and 11.5 vs. 9.3; p=0.001, respectively). A significant reduction in mean concentration of total cholesterol in females (203.4 vs. 193.1 mg/dL; p=0.001) and in males (209.5 vs. 201.9; p=0.002) was observed. The low-density lipoprotein cholesterol (LDL-C) levels decreased in females and in males (107.4 vs. 99.9 mg/dL; p=0.001 and 121.5 vs. 115.1; p=0.002, respectively). The apoAI concentrations increased in smoking women and in men with BMI ≥25 kg/m2 (p=0.032 and p=0.024, respectively). Conclusions Low-dose FA supplementation has a beneficial effect on blood lipids through decreasing concentrations of total cholesterol and LDL-C and increasing concentrations of apoAI.


European Journal of Preventive Cardiology | 2010

Does the progeny of premature ischemic stroke sufferers need intensive interest of physicians oriented toward primary prevention? A pilot study

Artur Mierzecki; Małgorzata Kozłowska-Wojciechowska; Hanna Bukowska; Magdalena Makarewicz-Wujec; Krystyna Honczarenko; Kornel Chełstowski; Maria Jastrzębska; Marta Masztalewicz

Background Few studies focus on the progeny of stroke patients with respect to the occurrence of other potential risk factors. Methods The study group covered 60 males and 62 females whose parents had suffered premature ischemic stroke (PIS); the control group comprised of 41 males and 47 females whose parents had no history of premature vascular event (mean age: 28.4 and 27.1 years, respectively). Examination of both the groups consisted of evaluation of their diet, measurement of arterial blood pressure and body mass index (BMI). Moreover, blood test was carried out and concentration of biochemical stroke risk factors was determined. Results The adult progeny of parents with a history of PIS followed a deficient, unbalanced, and nonvaried diet. Their average blood pressure and BMI reached higher values, compared with the results obtained in the control group (125.7 ± 16.06 vs. 122.64 ± 10.83 mmHg; 24.27 ± 3.98 vs. 22.54 ± 2.69 kg/m2, respectively; P<0.05). The same applies to average concentrations of the triglycerides 1.22 ± 0.76 vs. 1.06 ± 0.54 mmol/l; total cholesterol (5.34 ± 1.16 vs. 4.82 ± 0.89 mmol/l), low-density lipoprotein-cholesterol (2.95 ± 0.97 vs. 2.52 ± 0.73 mmol/l), total homocysteine (11.22 ± 4.22 vs. 10.18 ± 2.45 μmol/l), and fibrinogen (2.91 ± 0.68 vs. 2.78 ± 0.6 g/l) (P<0.05). Conclusion Adult children of PIS sufferers show different stroke risk factor profiles than the control group. It may indicate a need for preventive activities for this group in the future. Family occurrence of stroke requires further detailed studies on a larger cohort of patients from risk group.


Atherosclerosis | 1998

Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol.

Hanna Bukowska; J. Pieczul-Mróz; M. Jastrzębska; K. Chełstowski; Marek Naruszewicz


Atherosclerosis | 2007

Hyperhomocysteinemia in patients with symptomatic chronic heart failure: Prevalence and prognostic importance—pilot study

Marek Naruszewicz; Ewa A. Jankowska; Robert Zymliński; Hanna Bukowska; Barbara Millo; Waldemar Banasiak; Piotr Ponikowski


Metabolism-clinical and Experimental | 2005

Does the type of hormone replacement therapy affect lipoprotein (a), homocysteine, and C-reactive protein levels in postmenopausal women?

Hanna Bukowska; Stanisław Stanosz; Ewa Żochowska; Barbara Millo; Krzysztof Sieja; Kornel Chełstowski; Marek Naruszewicz


Archive | 1998

Use of lactobacillus for reduction of the fibrinogen level in blood

Hanna Bukowska; Marie-Louise Johansson; M. Naruszewicz


Journal of Biochemical and Biophysical Methods | 2004

A sensitive and specific HPLC method for the determination of total pentosidine concentration in plasma.

Dorota Słowik-Żłka; Krzysztof Safranow; Violetta Dziedziejko; Hanna Bukowska; Kazimierz Ciechanowski; Dariusz Chlubek


Polskie Archiwum Medycyny Wewnetrznej-polish Archives of Internal Medicine | 2001

[Reduction of the plasma LDL-cholesterol level among young healthy men as a result of the change from butter to soft margarine in the unbalanced diet].

Małgorzata Kozłowska-Wojciechowska; Hanna Bukowska; Magdalena Makarewicz-Wujec; Daniewski M; Marek Naruszewicz


Atherosclerosis | 1997

4.P.142 Effect of lactobacillus plantarum (pro viva) on LDL-cholesterol and fibrinogen levels in subjects with moderately elevated cholesterol

Hanna Bukowska; J. Pieczul-Mróz; K. Chełstowski; Marek Naruszewicz


Polskie Archiwum Medycyny Wewnetrznej-polish Archives of Internal Medicine | 2013

Homocysteine and metabolic risk factors in individuals with family history of premature ischemic stroke.

Artur Mierzecki; Hanna Bukowska; Karolina Kłoda; Kornel Chełstowski; Iwona Gorący; M. Naruszewicz

Collaboration


Dive into the Hanna Bukowska's collaboration.

Top Co-Authors

Avatar

Marek Naruszewicz

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Kornel Chełstowski

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar

Artur Mierzecki

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar

Barbara Millo

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Karolina Kłoda

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar

Maria Jastrzębska

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar

M. Naruszewicz

New York Academy of Medicine

View shared research outputs
Top Co-Authors

Avatar

Dariusz Chlubek

Pomeranian Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge